US Stock MarketDetailed Quotes
APLM Apollomics
- 8.900
- +0.740+9.07%
Close Nov 29 13:00 ET
- 9.210
- +0.310+3.48%
Post 16:52 ET
9.81MMarket Cap-171P/E (TTM)
9.240High7.820Low181.87KVolume8.160Open8.160Pre Close1.60MTurnover31.36%Turnover RatioLossP/E (Static)1.10MShares105.00052wk High0.47P/B5.16MFloat Cap7.55052wk Low--Dividend TTM579.88KShs Float4900.000Historical High--Div YieldTTM17.40%Amplitude7.550Historical Low8.790Avg Price1Lot Size
About Apollomics Company
Apollomics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of oncology therapies to address unmet medical needs. The company was founded by Liang Yu Guo and Sanjeev Redkar in 2015 and is headquartered in Foster City, CA.
Company Profile
SymbolAPLM
Company NameApollomics
Listing DateNov 26, 2021
Founded2015
CEODr. Guo-Liang Yu, PhD
MarketNASDAQ
Employees45
Fiscal Year Ends12-31
Address989 East Hillsdale Boulevard,Suite 220
CityFoster City
ProvinceCalifornia
CountryUnited States of America
Zip Code94404
Phone1-650-209-4055
Websitehttp://www.apollomicsinc.com
Company Executives
- Name
- Position
- Salary
- Dr. Guo-Liang Yu, PhD
- Chairman of the Board and Chief Executive Officer
- --
- Dr. Lijuan Jane Wang, PhD
- Chief Scientific Officer
- --
- Dr. Kin-Hung Peony Yu, M.D.
- Chief Medical Officer
- --
- Dr. Sanjeev Redkar, PhD
- President, Director and Principal Financial Officer
- --
- Dr. Jonathan Jian Wang, PhD
- Director
- --
- Wendy Hayes
- Director
- --
- Dr. Hong-Jung Moses Chen, PhD
- Independent Director
- --
- Glenn S. Vraniak
- Independent Director
- --
- Dr. Kenneth C. Carter, PhD
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data